Skip to search formSkip to main contentSkip to account menu

diacetolol

Known as: RS-1-(4-acetamido-2-acetylphenoxy)-2-hydroxy-3-isopropylaminopropane hydrochloride, acetamide, N-(3-acetyl-4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)phenyl)-, (+-)-, acetyl acebutolol 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1985
1985
The pharmacokinetics of acebutolol and its major metabolite, diacetolol, following a single 400 mg oral dose, were investigated… 
1985
1985
The cardioselectivity and specificity of diacetolol, the major metabolite of the beta-adrenoceptor blocking drug acebutolol, was… 
1984
1984
A new stereospecific hplc method that is capable of simultaneously quantitating the S‐(‐)‐ and R−(+)−enantiomers of acebutolol… 
1981
1981
1 The pharmacological effects and plasma levels of diacetolol, the major human metabolite of acebutolol, were measured in a… 
1981
1981
Acebutolol is a cardioselective /8-adrenoceptor blocking drug and has a major metabolite, diacetolol (Meffin, Harapat & Harrison… 
1981
1981
SummaryThe pharmacokinetics and bioavailability of diacetolol, the principal metabolite of acebutolol, were studied in 6 healthy… 
1980
1980
1 Acebutolol or diacetolol were added to fresh human plasma in varying concentrations and their extent of binding at 25 degrees C…